Retatrutide is designed for subcutaneous (under skin) injection into fat tissue
In CureCell we make Retatrutide in a strength of 15mg
That being said, there is no significant clinical evidence to support its long-term safety, nor is it FDA-approved
As a result, the drugs might reduce the effect of alcohol and help people drink less
For patients with type 2 diabetes, hemoglobin A1c should be measured at baseline and approximately every 3 months until glycemic targets are achieved, then at least twice yearly if stable
Alexandra-Elise Dakaud Patterson, MD, MS, is a general surgery resident at University of Toledo Medical Center and a member of the ABC News Medical Unit.